CVS Health Stock surges over 5% after stellar Q2 and huge profit upgrade for 2025

CVS Health stock jumped over 5% on Thursday morning right after the market opened. The jump happened because the company gave strong second-quarter results and raised its 2025 profit forecast, as per the CVS Health press release.

The company posted adjusted earnings per share (EPS) of $1.81 for Q2. Analysts were expecting only $1.45 EPS, so CVS beat the expectations. CVS reported revenue of $98.92 billion, which was up 8% compared to last year.

CVS beats revenue and profit expectations

Analysts had predicted revenue to be around $94.11 billion, so CVS did better here too. CVS Health is the parent company of CVS Pharmacy, CVS Caremark, and Aetna.


ALSO READ: Who could be California’s next governor after Kamala Harris bows out? These contenders are eyeing top job

CVS Health’s Chief Financial Officer Brian Newman said they’re pleased with their second strong quarter in 2025. He added that the company is handling a fast-changing environment while sticking to its main goals, as mentioned in the report by Investopedia.

CVS raises 2025 profit and cash flow forecast

He also said they’re staying focused on long-term value and keeping their financial promises. CVS increased its full-year 2025 adjusted EPS forecast to $6.30–$6.40, up from the earlier $6.00–$6.20 range.

The company also raised its 2025 expected cash flow from operations to at least $7.5 billion, up from about $7.0 billion. CVS stock has already gone up more than 45% so far in 2025, as stated by Investopedia.

FAQs

Q1. Why did CVS Health stock go up in July 2025?
CVS stock went up over 5% after strong Q2 results and a higher 2025 profit forecast.

Q2. What were CVS Health’s earnings and revenue in Q2 2025?
CVS reported $1.81 EPS and $98.92 billion in revenue, beating Wall Street estimates.